Investigation of unknown related substances in commercial erythromycin samples with liquid chromatography/mass spectrometry.

A selective reversed phase liquid chromatography/mass spectrometry (LC/MS(n)) method is described for the identification of erythromycin impurities and related substances in commercial erythromycin samples. Mass spectral data are acquired on a LCQ ion trap mass spectrometer equipped with an electrospray interface operated in positive ion mode. The LCQ is ideally suited for identification of impurities and related substances because it provides on-line LC/MS(n) capability. Compared with UV detection, this hyphenated LC/MS(n) technique provides as a main advantage efficient identification of novel substances without time-consuming isolation and purification procedures. Using this method four novel related substances were identified in commercial samples.

[1]  E. Roets,et al.  Separation of erythromycin and related substances on base-deactivated reversed-phase silica gel columns. , 2000, Journal of chromatography. A.

[2]  P. Leadlay,et al.  Structural elucidation studies of erythromycins by electrospray tandem mass spectrometry II. , 1999, Rapid communications in mass spectrometry : RCM.

[3]  R. B. Walker,et al.  Analysis of macrolide antibiotics. , 1998, Journal of chromatography. A.

[4]  I. Gilbert,et al.  Electrospray Mass Spectrometry for Assay of Erythromycin A Extracted From Fermentation Liquor , 1998 .

[5]  D. Volmer,et al.  Study of erythromycin A decomposition products in aqueous solution by solid-phase microextraction/liquid chromatography/tandem mass spectrometry. , 1998, Rapid communications in mass spectrometry : RCM.

[6]  P. Velagaleti,et al.  Sensitive determination of erythromycin in human plasma by LC-MS/MS. , 1998, Journal of pharmaceutical and biomedical analysis.

[7]  M. Nasr,et al.  High Performance Liquid Chromatographic Analysis of Erythromycin , 1996 .

[8]  E. Roets,et al.  Analysis of Erythromycin A and Its Metabolites in Biological Samples by Liquid Chromatography with Post-Column Ion-Pair Extraction , 1994 .

[9]  E. Roets,et al.  Evaluation of silanol-deactivated silica-based reversed phases for liquid chromatography of erythromycin , 1993 .

[10]  J. Hoogmartens,et al.  Macrolides, chemistry, pharmacology and clinical uses , 1993 .

[11]  J. Hoogmartens,et al.  Collaborative Study of the Analysis of Tylosin by Liquid Chromatography on Wide-Pore Poly(Styrene-Divinylbenzene) , 1993 .

[12]  J. Kelly,et al.  Determination of erythromycin A in salmon tissue by liquid chromatography with ion-spray mass spectrometry. , 1992, Biological mass spectrometry.

[13]  E. Roets,et al.  Liquid chromatography of erythromycin A and related substances on poly(styrene-divinylbenzene) , 1991 .

[14]  E. Roets,et al.  Improved Separation of Erythromycin on aged Reversed-Phase Columns. II , 1991 .

[15]  E. Roets,et al.  Quantitative analysis of erythromycin by reversed-phase liquid chromatography using column-switching. , 1991, Journal of pharmaceutical and biomedical analysis.

[16]  H. Kirst,et al.  Synthesis of ring-contracted derivatives of erythromycin , 1987 .

[17]  J. Hoogmartens,et al.  Translactonization in erythromycins , 1987 .

[18]  J. Hoogmartens,et al.  Identification of novel erythromycin derivatives in mother liquor concentrates of Streptomyces erythraeus. , 1987, The Journal of antibiotics.

[19]  E. Roets,et al.  Optimization of the separation of erythromycin and related substances by high-performance liquid chromatography. , 1987, Journal of chromatography.

[20]  E. Roets,et al.  Antibacterial activities of erythromycins A, B, C, and D and some of their derivatives , 1985, Antimicrobial Agents and Chemotherapy.

[21]  E. Roets,et al.  Separation of erythromycin and related substances by high-performance liquid chromatography on poly(styrene-divinylbenzene) packing materials. , 1985, Journal of chromatography.

[22]  E. Roets,et al.  Thin-layer chromatography of erythromycins and other macrolides , 1983 .

[23]  J. R. Martin,et al.  A new naturally occurring erythromycin: erythromycin F. , 1982, The Journal of antibiotics.

[24]  K. Tsuji,et al.  High-performance liquid chromatographic determination of erythromycin. , 1978, Journal of chromatography.

[25]  R. Egan,et al.  3-O-(2″,6″-dideoxy-α-l-ribo-hexopyranosyl)-erythronolide B and 3-O-(2″,6″,dideoxy-α-l-arabino-hexopyranosyl)erythronolide B, aberrant erythromycin biogenetic metabolites with defective sugar moities , 1976 .

[26]  R. Egan,et al.  Extension of the erythromycin biosynthetic pathway : Isolation and structure of erythromycin E , 1975 .

[27]  S. Ōmura,et al.  FAST LIQUID CHROMATOGRAPHY OF MACROLIDE ANTIBIOTICS , 1973 .

[28]  P. Wiley,et al.  Erythromycin. X.1 Structure of Erythromycin , 1957 .

[29]  P. Wiley,et al.  Erythromycin. I. Properties and Degradation Studies1 , 1954 .

[30]  J. W. Smith,et al.  [Ilotycin, a new antibiotic]. , 1952, Schweizerische medizinische Wochenschrift.